Get the Stockscreener App
2.77
12.60%
0.31
After Hours:
2.83
0.06
+2.17%
Aclarion Inc stock is traded at $2.77, with a volume of 176.78K.
It is up +12.60% in the last 24 hours and up +7.36% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
See More
Previous Close:
$2.46
Open:
$2.53
24h Volume:
176.78K
Relative Volume:
2.71
Market Cap:
$7.98M
Revenue:
$77,900
Net Income/Loss:
$-8.05M
P/E Ratio:
-0.3001
EPS:
-9.2296
Net Cash Flow:
$-7.47M
1W Performance:
+17.37%
1M Performance:
+7.36%
6M Performance:
+6.95%
1Y Performance:
-62.15%
1-Day Range:
$2.47
$2.78
1-Week Range:
$2.25
$2.78
52-Week Range:
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.77 | 7.09M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
238.34 | 39.60B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.38 | 12.21B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
51.64 | 9.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
102.33 | 8.76B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
57.99 | 7.31B | 638.78M | -22.66M | 122.18M | -0.1744 |
Aclarion Inc Stock (ACON) Latest News
Aclarion CEO Brent Ness buys $12,090 in company stock - Investing.com
Aclarion CEO Brent Ness buys $12,090 in company stock By Investing.com - Investing.com India
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion receives patent allowance for MRI scan technology By Investing.com - Investing.com Nigeria
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process - The Manila Times
Aclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc Evaluation - Quiver Quantitative
Aclarion receives patent allowance for MRI scan technology - Investing.com
Aclarion Receives Notice Of Allowance For Patent Advancing Accuracy And Adoption Of Nociscan's MR Spectroscopy Scan Process - marketscreener.com
Aclarion Inc (ACON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aclarion, Inc. Revenue Breakdown – FWB:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – BOATS:ACONW - TradingView
Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Aclarion, Inc. Q2 2026: Revenue $25.2K, EPS $(1.12) — 10-Q Summary - tradingview.com
Aclarion (NASDAQ: ACON) posts $5.6M H1 loss, holds $16.3M cash - Stock Titan
Aclarion Q2 FY26 net loss narrows 59.27% to $2.75 million; revenue rises 30.5% to $25,208 - Bitget
Aclarion Inc. Warrant (ACONW) Slips 2.39% but Remains Supported at $0.02Resistance Breakout Stocks - dars.gov.et
Aclarion (ACON) Slips 1.69% to $2.32: Stock Presses Against Support at $2.20Strong Buy Stocks - dars.gov.et
Aclarion’s Nociscan Expands to Goodman Campbell Brain & Spine in First Indiana Site - Quiver Quantitative
Aclarion, Inc Announces Nociscan Now Available At Goodman Campbell Brain & Spine At Ascension St. Vincent - marketscreener.com
Aclarion Inc. Warrant (ACONW) Surges 35% to $0.03, Trading at Critical JunctureETF Inflow Streak - dars.gov.et
Aclarion Inc. Warrant (ACONW) Holds at $0.02 as Trading Range Compresses to a PointFibonacci Retracement - dars.gov.et
Aclarion Inc. Warrant (ACONW) Flat at $0.02 as Support and Resistance ConvergeBuy Signal Reports - dars.gov.et
Aclarion reports 141% scan volume growth in first half of 2026 - Investing.com Nigeria
Aclarion, Inc. Revenue Breakdown – BOATS:ACON - TradingView
Aclarion Inc (ACON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aclarion Inc (ACON) Institutional Confidence - TradingKey
Aclarion Inc (ACON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Aclarion Inc (ACON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aclarion Inc (ACON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aclarion Inc (ACON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
ACON|Aclarion Inc|Price:2.420|Chg%:-0.030 - TradingKey
Aclarion Market Sentiment - Benzinga España
ACON|Aclarion Inc|Price:2.420|Chg%:+0.020 - TradingKey
TradingKey - TradingKey
Aclarion, Inc. Revenue Breakdown – TRADEGATE:IT20 - TradingView
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACONW - TradingView
Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice - orthospinenews.com
Aclarion Nociscan Case Reports 95% Relief Without Classic MRI Signs - Stock Titan
ACON Q1 2026 Earnings: Narrower Loss Beats Expectations, Stock RisesRetail Earnings Report - po-news-eg.net
Aclarion, Inc. Warrant 2022- on Aclarion Financial Disclosures & SEC Filings - TradingView
Aclarion Inc. (ACON) Q1 2026 Earnings: EPS Beat Estimates Despite No Reported RevenueEarnings Beat Alert - dars.gov.et
Return on equity % of Aclarion, Inc. – TRADEGATE:IT20 - TradingView
Aclarion Inc. (ACON) Slides 2.6% as Support Levels Face Renewed PressureDouble Bottom - dars.gov.et
Price to sales forward of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Number of shareholders of Aclarion, Inc. – NASDAQ:ACONW - TradingView
Price to earnings forward of Aclarion, Inc. – BOATS:ACONW - TradingView
ACON Q1 2026 Earnings: EPS Surprises to the Upside Despite Stock DeclinePerformance Review - DonanımHaber
Aclarion Inc. Warrants (ACONW) Trade Flat at Penny Levels Amid Minimal Price MovementIchimoku Kumo Twist - dars.gov.et
Aclarion Inc. (ACON) Consolidates Near $3.02 as Micro-Cap Healthcare Stock Eyes Resistance at $3.17Bullish Sentiment - dars.gov.et
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aclarion Inc Stock (ACON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
2.27%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):